Literature DB >> 8430966

The structure of large and small airways in nonfatal and fatal asthma.

N Carroll1, J Elliot, A Morton, A James.   

Abstract

Asthma is characterized by excessive airway narrowing and airway wall inflammation. In cases of fatal asthma, increased thickness of the airway wall is observed and may account for excessive airway narrowing when smooth muscle contracts. This study was undertaken to examine airway dimensions in large and small airways in both fatal and nonfatal cases of asthma. Airway wall areas (total, inner, and outer relative to smooth muscle layer), epithelial integrity, smooth muscle shortening, and the areas of smooth muscle, cartilage, and mucous glands were compared in transverse sections of large and small airways of subjects dying of asthma (fatal asthma, n = 11), those dying suddenly of nonrespiratory diseases and having a definite history of asthma (nonfatal asthma, n = 13), and those dying suddenly without any history of respiratory illness (control, n = 11). Airways were grouped by size using the basement membrane perimeter for comparison. All areas were expressed as areas per millimeter of basement membrane. In cartilaginous airways, the cases of fatal asthma had greater (p < 0.05) total wall, inner wall, outer wall, smooth muscle, mucous gland and cartilage areas than did control and nonfatal cases. The inner wall area was greater in the fatal and nonfatal cases than in the control cases (p < 0.05) in the small cartilaginous airways and membranous bronchioles (MB). In small MB (perimeter < 2 mm), the total and outer wall areas were greater (p < 0.05) in cases of fatal and nonfatal asthma than in control cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8430966     DOI: 10.1164/ajrccm/147.2.405

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  114 in total

Review 1.  Airway hyperresponsiveness in asthma: not just a matter of airway inflammation.

Authors:  V Brusasco; E Crimi; R Pellegrino
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 2.  Peripheral airways in asthma.

Authors:  Alan L James
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

Review 3.  New evidence of inflammation in asthma.

Authors:  A M Vignola; R Gagliardo; D Guerrera; G Chiappara; P Chanez; J Bousquet; G Bonsignore
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

4.  Extracellular matrix composition influences the resistance of airway remodelling events towards glucocorticoid treatment.

Authors:  Simon Pitchford; Clive Page
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 5.  Clinical assessment of airway remodeling in asthma: utility of computed tomography.

Authors:  Akio Niimi; Hisako Matsumoto; Masaya Takemura; Tetsuya Ueda; Yasutaka Nakano; Michiaki Mishima
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

Review 6.  Airway imaging in disease: gimmick or useful tool?

Authors:  Peter D Paré; Taishi Nagano; Harvey O Coxson
Journal:  J Appl Physiol (1985)       Date:  2012-05-17

Review 7.  Airway remodelling in asthma: from benchside to clinical practice.

Authors:  Céline Bergeron; Meri K Tulic; Qutayba Hamid
Journal:  Can Respir J       Date:  2010 Jul-Aug       Impact factor: 2.409

8.  Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease.

Authors:  John F Alcorn; Lisa M Rinaldi; Elizabeth F Jaffe; Mirjam van Loon; Jason H T Bates; Yvonne M W Janssen-Heininger; Charles G Irvin
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

9.  Production of TARC and MDC by naive T cells in asthmatic patients.

Authors:  Hirokuni Hirata; Masafumi Arima; Gang Cheng; Kyoko Honda; Fumiya Fukushima; Nozomi Yoshida; Fukiko Eda; Takeshi Fukuda
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

Review 10.  Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma.

Authors:  S S An; T R Bai; J H T Bates; J L Black; R H Brown; V Brusasco; P Chitano; L Deng; M Dowell; D H Eidelman; B Fabry; N J Fairbank; L E Ford; J J Fredberg; W T Gerthoffer; S H Gilbert; R Gosens; S J Gunst; A J Halayko; R H Ingram; C G Irvin; A L James; L J Janssen; G G King; D A Knight; A M Lauzon; O J Lakser; M S Ludwig; K R Lutchen; G N Maksym; J G Martin; T Mauad; B E McParland; S M Mijailovich; H W Mitchell; R W Mitchell; W Mitzner; T M Murphy; P D Paré; R Pellegrino; M J Sanderson; R R Schellenberg; C Y Seow; P S P Silveira; P G Smith; J Solway; N L Stephens; P J Sterk; A G Stewart; D D Tang; R S Tepper; T Tran; L Wang
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.